The stock of Mira Pharmaceuticals Inc (MIRA) has gone up by 11.34% for the week, with a -9.24% drop in the past month and a -6.09% drop in the past quarter. The volatility ratio for the week is 17.59%, and the volatility levels for the past 30 days are 10.79% for MIRA. The simple moving average for the past 20 days is 3.26% for MIRA’s stock, with a -16.54% simple moving average for the past 200 days.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
MIRA has 36-month beta value of 1.64. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for MIRA is 12.29M, and currently, short sellers hold a 5.74% ratio of that float. The average trading volume of MIRA on March 18, 2025 was 352.67K shares.
MIRA) stock’s latest price update
Mira Pharmaceuticals Inc (NASDAQ: MIRA)’s stock price has decreased by -8.47 compared to its previous closing price of 1.18. However, the company has seen a 11.34% increase in its stock price over the last five trading sessions. accessnewswire.com reported 2025-03-13 that MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This advancement expands the Company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief.
MIRA Trading at -4.84% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.44% of loss for the given period.
Volatility was left at 10.79%, however, over the last 30 days, the volatility rate increased by 17.59%, as shares sank -6.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.26% lower at present.
During the last 5 trading sessions, MIRA rose by +11.34%, which changed the moving average for the period of 200-days by +27.04% in comparison to the 20-day moving average, which settled at $1.0459. In addition, Mira Pharmaceuticals Inc saw -5.26% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who sale 55,410 shares at the price of $1.39 back on Nov 19 ’24. After this action, Aminov Erez now owns 1,105,790 shares of Mira Pharmaceuticals Inc, valued at $77,020 using the latest closing price.
Aminov Erez, the Chief Executive Officer of Mira Pharmaceuticals Inc, sale 44,590 shares at $1.27 during a trade that took place back on Nov 20 ’24, which means that Aminov Erez is holding 1,061,200 shares at $56,629 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -3.0. Equity return is now at value -192.32, with -169.22 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.11.
Conclusion
To put it simply, Mira Pharmaceuticals Inc (MIRA) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
